<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Genes &amp; Cells</journal-id><journal-title-group><journal-title xml:lang="en">Genes &amp; Cells</journal-title><trans-title-group xml:lang="ru"><trans-title>Гены и Клетки</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Genes and Cells</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-1829</issn><issn publication-format="electronic">2500-2562</issn><publisher><publisher-name xml:lang="en">Human Stem Cells Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">120750</article-id><article-id pub-id-type="doi">10.23868/201808024</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Dynamics of humanin release and consumption of amino acids by differentiating C2C12 myoblasts</article-title><trans-title-group xml:lang="ru"><trans-title>Динамика высвобождения хуманина и потребления аминокислот дифференцирующимися С2С12 миобластами</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zhloba</surname><given-names>A. A</given-names></name><name xml:lang="ru"><surname>Жлоба</surname><given-names>А. А</given-names></name></name-alternatives><email>zhloba@mail.spbnit.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Subbotina</surname><given-names>T. F</given-names></name><name xml:lang="ru"><surname>Субботина</surname><given-names>Т. Ф</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Smolina</surname><given-names>N. A</given-names></name><name xml:lang="ru"><surname>Смолина</surname><given-names>Н. А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kostareva</surname><given-names>A. A</given-names></name><name xml:lang="ru"><surname>Костарева</surname><given-names>А. А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.P. Pavlov First Saint Petersburg State Medical University</institution></aff><aff><institution xml:lang="ru">Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">V.A. Almazov National Medical Research Centre</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр им. В.А. Алмазова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2018</year></pub-date><volume>13</volume><issue>2</issue><issue-title xml:lang="en">VOL 13, NO2 (2018)</issue-title><issue-title xml:lang="ru">ТОМ 13, №2 (2018)</issue-title><fpage>77</fpage><lpage>82</lpage><history><date date-type="received" iso-8601-date="2023-01-05"><day>05</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Эко-Вектор</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://genescells.ru/2313-1829/article/view/120750">https://genescells.ru/2313-1829/article/view/120750</self-uri><abstract xml:lang="en"><p>In the differentiating culture of myoblasts, the formation of myofibrils is accompanied by the consumption of amino acids and the release of their derivatives into the medium. The enhancement of mitochondrial metabolism precedes the formation of myofibrils. In this work, the release of a humanin-like peptide (HNLP, mt-RNR-peptide) and amino acid derivatives into the medium was studied in the differentiation of C2C12 myoblasts. Cells of the C2C12 line were cultured using standard techniques in plates with control of myofibril formation and samples selection for analysis at 0 (induction), 2, 4, 7, 9 and 11 days of differentiation. HNLP was determined by enzyme immunoassay, and amino acids and their metabolites by liquid chromatography. From the essential amino acids, branched chain - Val, Leu, Ile were most intensively consumed up to day 7 of differentiation. There was observed a mutual correlation between the daily production of arginine derivatives - homoarginine (hArg) and ornithine (r = 0.53, p = 0.008) with a maximum on day 2, a significant decrease of hArg production on day 4 and trace secretion after day 7. The release of HNLP, unlike hArg, lasts up to 4 days. Secretion of HNLP in course differentiating myoblasts is an early marker of the mitochondrial metabolism development. Its decrease by day 7 is associated to inhibition of the further existence of already differentiated myocytes. The early stage of cell culture differentiation is more clearly checked not by the level of essential amino acids intake, which presented in the cultivation medium at high concentrations, but by the formation of amino acid products of specialized metabolic pathways, including hArg and ornithine. The metabolic activity of mitochondria is confirmed by the secretion of HNLP. The specific functional activity of myocytes depends on the metabolic activity of the mitochondria, which can be checked without violating the integrity of the culture, according to the level of secreted HNLP.</p></abstract><trans-abstract xml:lang="ru"><p>В дифференцирующейся культуре миобластов образование миофибрилл сопровождается потреблением аминокислот и высвобождением их производных в среду. Усиление митохондриального метаболизма предшествует образованию миофибрилл. Целью работы являлась оценка высвобождения в культуральную среду хуманиноподобного пептида (ХНПП, mtRNR-пептид) и производных аминокислот при дифференцировке С2С12 миобластов. Клетки линии С2С12 культивировали по стандартной методике в планшетах, контролируя образование миофибрилл и отбирая для анализа пробы культуральной среды на 0 (индукция), 2, 4, 7, 9 и 11 сут. дифференцировки. Уровень ХНПП определяли иммуноферментным методом, аминокислот и их метаболитов - жидкостной хроматографией. Из незаменимых аминокислот интенсивнее всех потребляются аминокислоты с разветвленной цепью - Вал, Лей, Иле вплоть до 7 сут. дифференцировки. Отмечается взаимная корреляция суточной продукции производных заменимой аминокислоты аргинина - гомоаргинина (гАрг) и орнитина (r=0,53; p=0,008) с максимумом на 2 сут., значительным снижением секреции гАрг на 4 сут. и следовой секрецией после 7 сут. дифференцировки. Высвобождение в среду ХНПП, в отличие от гАрг, продолжается до 4 сут. Начало дифференцировки клеточной культуры более четко прослеживалось не по уровню потребления незаменимых аминокислот, присутствующих в культуральной среде в высоких концентрациях, а по образованию аминокислот-продуктов специализированных метаболических путей, к числу которых относятся гАрг и орнитин. Метаболическая активность митохондрий подтверждается секрецией ХНПП. Секреция ХНПП дифференцирующимися миобластами является ранним маркером становления митохондриального метаболизма. Ее понижение к 7 сут. происходит на фоне деградации уже дифференцированных миоцитов. Специфическая функциональная активность миоцитов зависит от метаболической активности митохондрий, которую можно оценивать по уровню секретируемого ХНПП.</p></trans-abstract><kwd-group xml:lang="en"><kwd>humanin</kwd><kwd>myoblasts</kwd><kwd>differentiation</kwd><kwd>amino acids</kwd><kwd>homoarginine</kwd><kwd>mitochondria</kwd><kwd>humanin-like peptide</kwd><kwd>MT-RNR-peptides</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>хуманин</kwd><kwd>миобласты</kwd><kwd>дифференцировка</kwd><kwd>аминокислоты</kwd><kwd>гомоаргинин</kwd><kwd>митохондрии</kwd><kwd>хуманиноподобный пептид</kwd><kwd>mt-RNR-пептиды</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Lewis M.R., Lewis W.H. Mitochondria in tissue culture. Science. New Series 1914; 39(1000): 330-3.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Fujioka H., Tandler B., Consolo M.C. et al. Division of mitochondria in cultured human fibroblasts. Microscopy research and technique 2013; 76: 1213-6.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Carrillo-Cocom L.M., Genel-Rey T., Araiz-Hernândez D. et al. Amino acid consumption in naïve and recombinant CHO cell cultures: producers of a monoclonal antibody. Cytotechnology 2015; 67(5): 809-20.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Salazar A., Keusgen M., von Hagen J. Amino acids in the cultivation of mammalian cells. Amino Acids 2016; 48: 1161-71.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Hong P., Wheat T.E., Mazzeo J.R. et al. Monitoring cell culture media with the Waters amino acid analysis solution. Waters APPlications Notebook; 2007, http://www.waters.com/webassets/cms/library/docs/720002381en.pdf.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Lee C., Yen K., Cohen P. Humanin: a harbinger of mitochondrial-derived peptides? Trends Endocrinol. Metab. 2013; 24(5): 222-8.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Luciano F., Zhai D., Zhu X. et al. Cytoprotective peptide humanin binds and inhibits proapoptotic bcl-2/bax family protein bimEL. J. Biol. Chem. 2005; 280: 15825-35.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Remor A.P., de Matos F.J., Ghisoni K. et al. Differential effects of insulin on peripheral diabetes-related changes in mitochondrial bioenergetics: involvement of advanced glycosylated end products. Biochim. Biophys. Acta. 2011; 1812(11): 1460-71.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Bodzioch M., Lapicka-Bodzioch K., Zapala B. et al. Evidence for potential functionality of nuclearly-encoded humanin isoforms. Genomics 2009; 94(4): 247-56.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Биоинформационная база данных Uniprot [Электронный ресурс]. Available at: http://www.uniprot.org/uniprot/Q8IVG9 (accessed 23 may 2018).</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Yaffe D., Saxel O. A myogenic cell line with altered serum requirements for differentiation a myogenic cell line with altered serum requirements for differentiation. Differentiation 1977; 7(3): 159-66.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Niikura T., Sidahmed E., Hirata-Fukae C. et al. A humanin derivative reduces amyloid beta accumulation and ameliorates memory deficit in triple transgenic mice. PLoS ONE. 2011; 6(1): e16259.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Oh Y.K., Bachar A.R., Zacharias D.G. et al. Humanin preserves endothelial function and prevents atherosclerotic plaque progression in hypercholesterolemic ApoE deficient mice. Atherosclerosis 2011; 219(1): 65-73.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Keire P., Shearer A., Shefer G. et al. Isolation and culture of skeletal muscle myofibers as a means to analyze satellite cells. Meth. Mol. Biol. 2013; 946: 431-68.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Жлоба А.А., Субботина Т.Ф., Шипаева К.А. Способ определения содержания гомоаргинина в плазме крови и других биологических жидкостях человека. Патент РФ на изобр. № 2609873. 06 февраля 2017.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Burattini S., Ferri P., Battistelli M. et al. C2C12 murine myoblasts as a model of skeletal muscle development: morpho-functional characterization. Eur. J. Histochem. 2004; 48(3): 223-33.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Hou Y., Hu S., Jia S. et al. Whole-body synthesis of L-homoarginine in pigs and rats supplemented with L-arginine. Amino Acids 2016; 48: 993-1001.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Braissant O., Henry H., Villard A.M. et al. Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1. BMC developmental biology. 2005; 5: 9.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Sandell L.L., Guan X.J., Ingram R., Tilghman S.M. Gatm, a creatine synthesis enzyme, is imprinted in mouse placenta. PNAS USA 2003; 100(8): 4622-7.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Nashine S., Cohen P., Chwa M. et al. Humanin G (HNG) protects age-related macular degeneration (AMD) transmitochondrial ARPE-19 cybrids from mitochondrial and cellular damage. Cell Death Dis. 2017; 8(7): e2951.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Herst P.M., Rowe M.R., Carson G.M. et al. Functional mitochondria in health and disease. Front. Endocrinol. 2017; 8: 296.</mixed-citation></ref></ref-list></back></article>
